Literature DB >> 10392864

Influence of lesion length on restenosis after coronary stent placement.

A Kastrati1, S Elezi, J Dirschinger, M Hadamitzky, F J Neumann, A Schömig.   

Abstract

The length of a coronary lesion is a significant predictor of restenosis after balloon angioplasty. The influence of lesion length has not comprehensively been assessed after coronary stent placement. This study includes 2,736 consecutive patients with coronary stent placement. Only patients with recent or chronic occlusions before the intervention were excluded. Patients were divided in 2 groups: 573 patients with long lesions (> or = 15 mm) and 2,163 patients with short lesions (< 15 mm). There were no significant differences between the groups with respect to the procedural success rate and incidence of subacute thrombosis. One-year event-free survival was lower in patients with long lesions (73.3% vs 80.0%, p = 0.001). Six-month angiography was performed in 82.5% of the eligible patients. The incidence of binary restenosis (> or = 50% diameter stenosis) was higher in patients with long lesions (36.9% vs 27.9%, p <0.001). Similarly, patients with long lesions presented more late lumen loss than those with short lesions (1.29 +/- 0.89 vs 1.07 +/- 0.77 mm, p <0.001). Multivariate models for both binary restenosis and late lumen loss demonstrated that lesion length was an independent risk factor for restenosis. The risk was further increased by multiple stent placement and overlapping stents that were also independent risk factors of restenosis. Stented segment length did not show any independent effect. Therefore, long lesions represent an independent risk factor for restenosis after coronary stent placement. The results of this study suggest that a possible way to reduce the risk is to cover the lesion with a minimal number of nonoverlapping stents.

Entities:  

Mesh:

Year:  1999        PMID: 10392864     DOI: 10.1016/s0002-9149(99)00165-4

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  24 in total

1.  Drug eluting stents: maximising benefit and minimising cost.

Authors:  J Gunn; A C Morton; C Wales; C M H Newman; D C Crossman; D C Cumberland
Journal:  Heart       Date:  2003-02       Impact factor: 5.994

Review 2.  Current understanding of coronary in-stent restenosis. Pathophysiology, clinical presentation, diagnostic work-up, and management.

Authors:  T M Schiele
Journal:  Z Kardiol       Date:  2005-11

3.  The Sirolimus-eluting coronary stent in daily routine practice in Germany: trends in indications over the years. Results from the prospective multi-centre German Cypher Stent Registry.

Authors:  Ralf Zahn; C W Hamm; S Schneider; U Zeymer; G Richardt; M Kelm; B Levenson; T Bonzel; U Tebbe; G Sabin; C A Nienaber; Thomas Pfannebecker; J Senges
Journal:  Clin Res Cardiol       Date:  2007-06-04       Impact factor: 5.460

Review 4.  Percutaneous coronary intervention: balloons, stents and scaffolds.

Authors:  Roisin Colleran; Adnan Kastrati
Journal:  Clin Res Cardiol       Date:  2018-07-23       Impact factor: 5.460

5.  Applying the National Institute for Clinical Excellence criteria to patients treated with the Genous™ Bio-engineered R stent™: a sub-study of the e-HEALING (Healthy Endothelial Accelerated Lining Inhibits Neointimal Growth) worldwide registry.

Authors:  Margo Klomp; Peter Damman; Marcel A M Beijk; Sigmund Silber; Manfred Grisold; Expedito E Ribeiro; Harry Suryapranata; Jaroslaw Wòjcik; Kui Hian Sim; Jan G P Tijssen; Robbert J de Winter
Journal:  Heart Vessels       Date:  2011-07-02       Impact factor: 2.037

6.  Side branch healing patterns of the Tryton dedicated bifurcation stent: a 1-year optical coherence tomography follow-up study.

Authors:  Maik J Grundeken; Hector M Garcia-Garcia; Robin P Kraak; P Woudstra; Daniel M de Bruin; Ton G van Leeuwen; Karel T Koch; Jan G Tijssen; Robbert J de Winter; Joanna J Wykrzykowska
Journal:  Int J Cardiovasc Imaging       Date:  2014-07-26       Impact factor: 2.357

7.  Carotid artery stenting using a novel self-expanding braided nickel-titanium stent: feasibility and safety porcine trial.

Authors:  Frank Ahlhelm; Ralf Kaufmann; Dirk Ahlhelm; Mai Fang Ong; Christian Roth; Wolfgang Reith
Journal:  Cardiovasc Intervent Radiol       Date:  2009-06-16       Impact factor: 2.740

Review 8.  Drug-eluting stents: new era and new concerns.

Authors:  V Bhatia; R Bhatia; M Dhindsa
Journal:  Postgrad Med J       Date:  2004-01       Impact factor: 2.401

9.  Impact of metabolic syndrome and C-reactive protein on outcome after coronary stenting.

Authors:  G R Iturry-Yamamoto; A C Zago; E H Moriguchi; W C Manfroi; J L Camargo; J L Gross; A J Zago
Journal:  J Endocrinol Invest       Date:  2009-04       Impact factor: 4.256

10.  Multiple sequential complications after sirolimus-eluting stent implantation: very late stent thrombosis, stent fracture, in-stent restenosis, and peri-stent aneurysm.

Authors:  Sang-Hoon Seol; Doo-Il Kim; Yang-Chun Han; Ki-Hun Kim; Dong-Kie Kim; Young-Bok Kim; Ung Kim; Tae-Hyun Yang; Dae-Kyeong Kim; Dong-Soo Kim
Journal:  Korean Circ J       Date:  2009-10-28       Impact factor: 3.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.